Jason Tardio, Chief Operating Officer at Ovid Therapeutics Inc. (OVID), sold 17,344 shares at $2.15 ($37K) on 2022-09-12, disclosed to the SEC on 2022-09-14.
Open-market sale of $37k OVID by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.